Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Sarcoma 6Triple Negative Breast Neoplasms 2Pathologic Complete Response 2Osteosarcoma 2Hemangiosarcoma 2Breast Neoplasms 2Bone Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Recurrence 1Rectal Neoplasms 1Patient Compliance 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Melanoma 1Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion 1Leukemia, Myeloid, Acute 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Esophageal Neoplasms 1Endometrial Clear Cell Adenocarcinoma 1Disease Progression 1Colonic Neoplasms 1Chondrosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Standard of Care 1Practice Guidelines as Topic 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Clear Cell Adenocarcinoma × Standard of Care × Sarcoma × Clear all
NCT03422198 2025-12-12

SAVE

University of Utah

Phase 3 Recruiting
188 enrolled 15 charts
GynecologicSarcoma

Endometrial Clear Cell Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡